AwardedSpainGoods€702,075
Suministro de Ramucirumab 10mg/ml inyectable perfusión de 10ml y 50ml (CYRAMZA) de distribución exclusiva con destino al Servicio de farmacia del Hospital Clínico San Carlos de Madrid
- Published
- Published 27 April 2026
Overview
Hospital Clínico San Carlos de Madrid has awarded a contract to LILLY, S.A. for the exclusive supply of Ramucirumab 10mg/ml injectable infusion in 10ml and 50ml vials (CYRAMZA) to its pharmacy service. The award value is 319,125 EUR, completed on 23 April 2026.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €702,075
- Procedure
- Direct
- Published
- 27 April 2026
Pharmaceutical products
Award outcome
- Awarded value
- €319,125
- Award date
- 23 April 2026
- Contract period
- — → 12 April 2028
- LILLY, S.A
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 April 2026
Contracting authority
HOSPITAL CLINICO SAN CARLOS DE MADRID
Procuring entityMADRID, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.